FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Weir

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Michael A Weber; Matthew R Weir; Dion H Zappe; Ying Zhang; George L Bakris; Bjorn Dahlof; Kenneth A Jamerson; Eric J Velazquez; Bertram Pitt
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
C. Daniel Mullins; Françoise Pradel; Ya-Chen Tina Shih; Matthew R Weir; Kaloyan Bikov; Christine S Franey; Rahul Jain; Stephen T Bartlett
Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease.
Raymond R Townsend; Matthew R Weir
Angiotensin II blockade after kidney transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Weir (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael A Weber; Matthew R Weir; Dion H Zappe; Ying Zhang; George L Bakris; Bjorn Dahlof; Kenneth A Jamerson; Eric J Velazquez; Bertram Pitt
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Lancet 2013;381(9866):537-45.
2013: C. Daniel Mullins; Françoise Pradel; Ya-Chen Tina Shih; Matthew R Weir; Kaloyan Bikov; Christine S Franey; Rahul Jain; Stephen T Bartlett
Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease.
Transplantation 2013;95(3):463-9.
2013: Raymond R Townsend; Matthew R Weir
Angiotensin II blockade after kidney transplantation.
Journal of the American Society of Nephrology : JASN 2013;24(2):167-8.
2013: John C Papadimitriou; Emilio Ramos; Richard Ugarte; Matthew R Weir; Charles B Cangro; Cinthia Drachenberg; David K Klassen; Debra Kukuruga; Joseph Nogueira; Abdolreza Haririan
Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies.
Transplantation 2013;95(1):128-36.
2012: Henry Krum; Loren Laine; Paul M Peloso; Steven S Smugar; Gary Swergold; Hongwei Wang; Matthew R Weir; D Craig Brater; Sean P Curtis; Arnold Gammaitoni; Amarjot Kaur; Christopher P Cannon
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.
Cardiovascular therapeutics 2012;30(6):342-50.
2012: Matthew R Weir
Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position.
Journal of the American Society of Hypertension : JASH 2012;6(6):443-7.
2012: Feras Karadsheh; Matthew R Weir
Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.
Current hypertension reports 2012;14(5):416-20.
2012: Amanda Hyre Anderson; Jing Chen; Harold I Feldman; Tom Greene; Chi-yuan Hsu; Bernard G Jaar; Marshall M Joffe; Patricia Kao; John W Kusek; J Richard Landis; James P Lash; Mary B Leonard; Raymond R Townsend; Matthew R Weir; Dawei Xie; Wei Yang
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(2):250-61.
2012: Matthew R Weir; Cinthia Drachenberg
A 72-year-old woman with several months of weight loss and generalized weakness.
The American journal of the medical sciences 2012;344(2):142-5.
2012: Krista L Lentine; Michael Ragosta; John F Robb; Matthew R Weir; Andrew D Auerbach; Kline Bolton; Robert L Carithers; Salvatore P Costa; Kim A Eagle; Lee A Fleisher; Bertram L Kasiske
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
Journal of the American College of Cardiology 2012;60(5):434-80.
2012: Krista L Lentine; Michael Ragosta; John F Robb; Matthew R Weir; Andrew D Auerbach; Kline Bolton; Robert L Carithers; Salvatore P Costa; Kim A Eagle; Lee A Fleisher; Bertram L Kasiske
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation.
Circulation 2012;126(5):617-63.
2012: Matthew R Weir
Improving the estimating equation for GFR--a clinical perspective.
The New England journal of medicine 2012;367(1):75-6.
2012: Myra A Carpenter; Andrew A House; Deborah B Adey; Andrew G Bostom; Matthew R Weir; John W Kusek
Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study.
Clinical transplantation 2012;26(4):E438-46.
2012: Viresh Mohanlal; Afshin Parsa; Matthew R Weir
Role of dietary therapies in the prevention and treatment of hypertension.
Nature reviews. Nephrology 2012;8(7):413-22.
2012: JULIA SCIALLA; Stephen M Sozio; Raymond R Townsend; Matthew R Weir; Myles Wolf; Wei Yang; Xiaoming Zhang; Cheryl A M Anderson; Lawrence J Appel; Lydia A Bazzano; Magdalena Cuevas; Melanie J Glenn; Radhakrishna R Kallem; Eva Lustigova; Edgar R Miller; Anna Christine Porter
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2012;22(4):379-388.e1.
2012: Matthew R Weir; Rajiv Agarwal
Thiazide and thiazide-like diuretics: perspectives on individualization of drug and dose based on therapeutic index.
Hypertension 2012;59(6):1089-90.
2012: Heather Jones; David K Klassen; Joseph Nogueira; Hassaan Rasheed; Manish Talwar; Richard Ugarte; Matthew R Weir; Charles B Cangro; Abdolreza Haririan
Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.
Transplantation 2012;93(9):923-8.
2012: Mark K Greathouse; Matthew R Weir
The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
Postgraduate medicine 2012;124(2):40-52.
2012: Matthew R Weir; Jackson T Wright; George L Bakris; Bjorn Dahlof; Richard B Devereux; R Allen Hester; Tsushung A Hua; Roxzana Y Kelly; Sverre E Kjeldsen; Bertram Pitt; Eric Velazquez; Michael A Weber; Kenneth A Jamerson
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Kidney international 2012;81(6):568-76.
2012: Afshin Parsa; Alan R Shuldiner; Matthew R Weir; Eric Brown; Jeffrey C Fink; Braxton D Mitchell; Patrick F McArdle
Genotype-based changes in serum uric acid affect blood pressure.
Kidney international 2012;81(5):502-7.
2012: Matthew R Weir; Stephen T Bartlett; Cinthia Drachenberg
Eosinophilia as an early indicator of pancreatic allograft rejection.
Clinical transplantation 2012;26(2):238-41.
2012: Matthew R Weir; Cheryl A M Anderson; Lawrence J Appel; Jing Chen; Jeffrey C Fink; Jiang He; Natasha Litbarg; Akinlolu O Ojo; Mahboob Rahman; Leigh Rosen; Stephen M Sozio; Susan Steigerwalt; Louise Strauss; Valerie Teal; Raymond R Townsend; Sharon Turban; Marshall M Joffe
Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort study.
American journal of nephrology 2012;36(5):397-404.
2012: Eberechukwu Onukwugha; Françoise Pradel; Elijah Saunders; F Ellen Loh; C. Daniel Mullins; Marni Zuckerman; Matthew R Weir
A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting.
BMJ open 2012;2(4):.
2012: Krupa Patel; Loreen D Walker; Matthew R Weir; Min Zhan; Clarissa Diamantidis; James Gardner; Van Doren Hsu; Jeffrey C Fink
Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.
American journal of nephrology 2012;36(1):19-26.
2011: Matthew R Weir
Recognizing the link between chronic kidney disease and cardiovascular disease.
The American journal of managed care 2011;17 Suppl 15():S396-402.
2011: Matthew R Weir
Body mass index-mortality paradox in hemodialysis patients: blood pressure, blood volume, and nutritional status.
Hypertension 2011;58(6):989-90.
2011: May Montasser; Afshin Parsa; Cristopher V Van Hout; Robert A Vogel; Marie-Hélène Roy-Gagnon; Julie A Douglas; Yen-Pei C Chang; Matthew R Weir; Soren Snitker; Alan R Shuldiner; Nanette I Steinle; Nga H Brereton; Braxton D Mitchell
Determinants of blood pressure response to low-salt intake in a healthy adult population.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(11):795-800.
2011: Matthew R Weir
Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration.
Kidney international 2011;80(10):1016-7.
2011: JULIA SCIALLA; Jing Chen; Melanie Glenn; Rulan S Parekh; Sylvia E Rosas; Mary B Leonard; Raymond R Townsend; Stephen L Seliger; Crystal A Gadegbeku; Dominic Raj; Matt J Budoff; Matthew R Weir; Myles Wolf; Asaf Hanish; Eva Lustigova; Lawrence J Appel
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(11):2612-9.
2011: Matthew R Weir
Optimal treatment strategies for patients with hypertension and diabetes: are effects on metabolism important?
Hypertension 2011;58(5):758-9.
2011: Chi-yuan Hsu; Edgar R Miller; Akinlolu O Ojo; Kathleen Propert; Michael Shlipak; Valerie Teal; Raymond Townsend; Matthew R Weir; Jillian Wilson; Dawei Xie; Harold Feldman; Lee Hamm; Jiang He
Measured GFR does not outperform estimated GFR in predicting CKD-related complications.
Journal of the American Society of Nephrology : JASN 2011;22(10):1931-7.
2011: Matthew R Weir; Cheryl A M Anderson; Lawrence J Appel; Jing Chen; Jeffrey C Fink; Jiang He; Natasha Litbarg; Akinlolu O Ojo; Mahboob Rahman; Leigh Rosen; Stephen M Sozio; Susan Steigerwalt; Louise Strauss; Valerie Teal; Raymond R Townsend; Marshall M Joffe
Hemodynamic correlates of proteinuria in chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(10):2403-10.
2011: Matthew R Weir; Dion H Zappe; Norman K Hollenberg; Xiangyi Meng; Giuseppe Remuzzi; Hans-Henrik Parving
Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients.
Journal of hypertension 2011;29(10):2031-7.
2011: Matthew R Weir; Daniel J Salzberg
Management of hypertension in the transplant patient.
Journal of the American Society of Hypertension : JASH 2011;5(5):425-32.
2011: Joseph L Izzo; Matthew R Weir
Angiotensin-converting enzyme inhibitors.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(9):667-75.
2011: Abdolreza Haririan; David K Klassen; M Metireddy; Joseph Nogueira; Flavio H Rasetto; Charles B Cangro; Matthew Cooper; Matthew R Weir
Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011;11(9):1943-50.
2011: Matthew R Weir
Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success?
Kidney international 2011;80(3):235-7.
2011: Stephen L Seliger; Loreen Walker; Matthew R Weir; Amy D Zhang; Clarissa Diamantidis; Van Doren Hsu; Afshin Parsa; Jeffrey C Fink
Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.
Kidney international 2011;80(3):288-94.
2011: Matthew R Weir; Chunlin Qian; Ali Shojaee; William F Waverczak; Alan Graff; Willa A Hsueh; Christopher J Jones; Thomas J Littlejohn; Shawna D Nesbitt; Joel M Neutel
A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(6):404-12.
2011: Arya M Sharma; Matthew R Weir
The role of angiotensin receptor blockers in diabetic nephropathy.
Postgraduate medicine 2011;123(3):109-21.
2011: Roland E Schmieder; George Bakris; Matthew R Weir
Telmisartan in incipient and overt diabetic renal disease.
Journal of nephrology 2011;24(3):263-73.
2011: Andrew G Bostom; Myra A Carpenter; John W Kusek; Andrew S Levey; Lawrence Hunsicker; Marc A Pfeffer; Jacob Selhub; Paul F Jacques; Edward Cole; Lisa Gravens-Mueller; Andrew A House; Clifton Kew; Joyce L McKenney; Alvaro Pacheco-Silva; Todd Pesavento; John Pirsch; Stephen Smith; Scott Solomon; Matthew R Weir
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
Circulation 2011;123(16):1763-70.
2011: Matthew R Weir; Shamkant Mulgaonkar; Laurence Chan; Hamid Shidban; Thomas H Waid; Dennis Preston; Roberto N Kalil; Thomas C Pearson
Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.
Kidney international 2011;79(8):897-907.
2011: Matthew R Weir; Dion H Zappe; L A Orloski; James R Sowers
How early should blood pressure control be achieved for optimal cardiovascular outcomes?
Journal of human hypertension 2011;25(4):211-7.
2011: Matthew R Weir
Leadership message: government and corporate responsibility to work with academia about the obesity epidemic.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(3):217-8.
2011: Gearoid McMahon; Matthew R Weir; Xian C Li; Didier A Mandelbrot
The evolving role of mTOR inhibition in transplantation tolerance.
Journal of the American Society of Nephrology : JASN 2011;22(3):408-15.
2011: Eberechukwu Onukwugha; C. Daniel Mullins; F Ellen Loh; Elijah Saunders; Fadia T. Shaya; Matthew R Weir
Readmissions after unauthorized discharges in the cardiovascular setting.
Medical care 2011;49(2):215-24.
2011: Kenneth A Jamerson; Richard Devereux; George L Bakris; Björn Dahlöf; Bertram Pitt; Eric J Velazquez; Matthew R Weir; Roxzana Y Kelly; Tsushung A Hua; Allen Hester; Michael A Weber
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
Hypertension 2011;57(2):174-9.
2011: Matthew R Weir; Solomon Aronson; Edwin G Avery; Charles V Pollack
Acute kidney injury following cardiac surgery: role of perioperative blood pressure control.
American journal of nephrology 2011;33(5):438-52.
2011: Matthew R Weir; Henry A Punzi; John M Flack; Kathy A Stoakes; Kathleen J Chavanu; Wei Li; Robert Dubiel
A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.
Postgraduate medicine 2011;123(1):80-7.
2011: Ravinder K Wali; Malini Iyengar; Gerald J Beck; David M Chartyan; Michel Chonchol; Mary Ann Lukas; Christopher Cooper; Jonathan Himmelfarb; Matthew R Weir; Tomas Berl; William Henrich; Alfred K Cheung
Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Circulation. Heart failure 2011;4(1):18-26.
2010: Matthew R Weir; Anthony M Yadao; Das Purkayastha; Alan N Charney
Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren.
Journal of cardiovascular pharmacology and therapeutics 2010;15(4):356-63.
2010: Joseph Nogueira; Matthew R Weir; Stephen C Jacobs; Denyse Breault; David K Klassen; Debora A Evans; Stephen T Bartlett; Matthew Cooper
A study of renal outcomes in obese living kidney donors.
Transplantation 2010;90(9):993-9.
2010: Matthew R Weir
Can the early elimination of calcineurin inhibitors result in clinical benefits?
Transplantation proceedings 2010;42(9 Suppl):S16-20.
2010: Alan H Gradman; Matthew R Weir; M Wright; C A Bush; D L Keefe
Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
Journal of human hypertension 2010;24(11):721-9.
2010: Matthew R Weir; George L Bakris
Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study.
Current hypertension reports 2010;12(5):313-5.
2010: Michael R Lattanzio; Matthew R Weir
Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
Current hypertension reports 2010;12(5):369-77.
2010: Eberechukwu Onukwugha; Elijah Saunders; C. Daniel Mullins; Françoise Pradel; Marni Zuckerman; Matthew R Weir
Reasons for discharges against medical advice: a qualitative study.
Quality & safety in health care 2010;19(5):420-4.
2010: Larry A Weinrauch; Jennifer Sun; Ray E Gleason; Guenther H Boden; R H Creech; George Dailey; Frank P Kennedy; Matthew R Weir; John A D'Elia
Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(10):1429-34.
2010: Marie Russell; Angela Silverman; Jerome L Fleg; Elisa T Lee; Mihriye Mete; Matthew R Weir; Charlton Wilson; Fawn Yeh; Barbara V Howard; W M James Howard
Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.
Journal of clinical lipidology 2010;4(5):435-43.
2010: Matthew R Weir
Dietary fructose and elevated levels of blood pressure.
Journal of the American Society of Nephrology : JASN 2010;21(9):1416-8.
2010: Michael R Lattanzio; Matthew R Weir
Have we fallen off target with concerns surrounding dual RAAS blockade?
Kidney international 2010;78(6):539-45.
2010: Raymond R Townsend; Julio A Chirinos; Afshin Parsa; Matthew R Weir; Stephen M Sozio; James P Lash; J Chen; Susan P Steigerwalt; Alan S Go; Chi-Yuan Hsu; Mohammed Rafey; Jackson T Wright; Mark J Duckworth; Crystal A Gadegbeku; Marshall P Joffe
Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study.
Hypertension 2010;56(3):518-24.
2010: Lalitha De Silva; Matthew R Weir
Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
Current opinion in nephrology and hypertension 2010;19(5):437-43.
2010: Matthew R Weir
Hypervolemia and blood pressure: powerful indicators of increased mortality among hemodialysis patients.
Hypertension 2010;56(3):341-3.
2010: Rajiv Agarwal; Matthew R Weir
Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(7):1255-60.
2010: Michael A Weber; George L Bakris; Kenneth A Jamerson; Matthew R Weir; Sverre E Kjeldsen; Richard B Devereux; Eric J Velazquez; Björn Dahlöf; Roxzana Y Kelly; Tsushung Hua; Allen Hester; Bertram Pitt
Cardiovascular events during differing hypertension therapies in patients with diabetes.
Journal of the American College of Cardiology 2010;56(1):77-85.
2010: Lynda A Szczech; Christopher B Granger; Joseph F Dasta; Alpesh Amin; W Frank Peacock; Peter A McCullough; John W Devlin; Matthew R Weir; Jason N Katz; Frederick A Anderson; Allison Wyman; Joseph Varon
Acute kidney injury and cardiovascular outcomes in acute severe hypertension.
Circulation 2010;121(20):2183-91.
2010: Charlton Wilson; Chun-Chih Huang; Nawar Shara; Barbara V Howard; Jerome L Fleg; Jeffrey A Henderson; Wm James Howard; Heather Huentelman; Elisa T Lee; Mihriye Mete; Marie Russell; James M Galloway; Angela Silverman; Mario Stylianou; Jason Umans; Matthew R Weir; Fawn Yeh; Robert E Ratner
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
Journal of clinical lipidology 2010;4(3):165-72.
2010: Joseph Nogueira; Abdolreza Haririan; Stephen C Jacobs; Matthew Cooper; Matthew R Weir
Cigarette smoking, kidney function, and mortality after live donor kidney transplant.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(5):907-15.
2010: Matthew R Weir; Fritz Diekmann; Stuart M Flechner; Yvon Lebranchu; Didier A Mandelbrot; Rainer Oberbauer; Barry D Kahan
mTOR inhibition: the learning curve in kidney transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2010;23(5):447-60.
2010: George L Bakris; Pantelis A Sarafidis; Matthew R Weir; Björn Dahlöf; Bertram Pitt; Kenneth A Jamerson; Eric J Velazquez; Linda Staikos-Byrne; Roxzana Y Kelly; Victor Shi; Yann-Tong Chiang; Michael A Weber
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Lancet 2010;375(9721):1173-81.
2010: Matthew R Weir
Hypertension: Endothelin-receptor antagonists for treating hypertension.
Nature reviews. Nephrology 2010;6(4):192-4.
2010: Abdolreza Haririan; Joseph Nogueira; Joseph M Noguiera; Kambiz Zandi-Nejad; Ravi Aiyer; Heather Hurley; Matthew Cooper; David K Klassen; Matthew R Weir
The independent association between serum uric acid and graft outcomes after kidney transplantation.
Transplantation 2010;89(5):573-9.
2010: Matthew R Weir; Mark Rolfe
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(3):531-48.
2010: Raymond R Townsend; Neil J Wimmer; Julio A Chirinos; Afshin Parsa; Matthew R Weir; Kalyani Perumal; James P Lash; Jing Chen; Susan P Steigerwalt; John M Flack; Alan S Go; Mohammed Rafey; Mahboob Rahman; Angela Sheridan; Crystal A Gadegbeku; Nancy A Robinson; Marshall Joffe
Aortic PWV in chronic kidney disease: a CRIC ancillary study.
American journal of hypertension 2010;23(3):282-9.
2010: Paul Muntner; Amanda Anderson; Jeanne Charleston; Zhen Chen; Virginia Ford; Gail Makos; Andrew O'Connor; Kalyani Perumal; Mahboob Rahman; Susan Steigerwalt; Valerie Teal; Raymond Townsend; Matthew R Weir; Jackson T Wright
Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(3):441-51.
2010: Matthew R Weir
Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patient.
Hypertension 2010;55(2):226-7.
2010: Lesley A Stevens; Christopher Schmid; Yaping L Zhang; Josef Coresh; Jane Manzi; Richard Landis; Omran Bakoush; Gabriel Contreras; Saul Genuth; Goran B Klintmalm; Emilio Poggio; Peter Rossing; Andrew D Rule; Matthew R Weir; John W Kusek; Tom Greene; Andrew S Levey
Development and validation of GFR-estimating equations using diabetes, transplant and weight.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(2):449-57.
2010: Matthew R Weir; George L Bakris
Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
American journal of nephrology 2010;31(5):469-70.
2010: Marshall Joffe; Chi-yuan Hsu; Harold I Feldman; Matthew R Weir; J R Landis; L Lee Hamm
Variability of creatinine measurements in clinical laboratories: results from the CRIC study.
American journal of nephrology 2010;31(5):426-34.
2010: Matthew R Weir; Lori L Bogle; Philip A Mackowiak
The death of John Paul Jones and resurrection as 'father of the US Navy'.
American journal of nephrology 2010;31(1):90-4.
2010: Matthew R Weir; Norman K Hollenberg; Dion H Zappe; Xiangyi Meng; Hans-Henrik Parving; Giancarlo Viberti; Giuseppe Remuzzi
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuria.
Journal of hypertension 2010;28(1):186-93.
2009: Joseph Nogueira; Matthew R Weir; Stephen C Jacobs; Abdolreza Haririan; Denyse Breault; David K Klassen; Deb Evans; Stephen T Bartlett; Matthew Cooper
A study of renal outcomes in African American living kidney donors.
Transplantation 2009;88(12):1371-6.
2009: Matthew R Weir
Hypertension and the kidney: perspectives on the relationship of kidney disease and cardiovascular disease.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(12):2045-50.
2009: Melissa Badowski; Cheryle Gurk-Turner; Charles B Cangro; Matthew R Weir; Benjamin Philosophe; David K Klassen; Abdolreza Haririan
The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients.
Clinical transplantation 2009;23(6):930-7.
2009: Matthew R Weir; Fawn Yeh; Angela Silverman; Richard B Devereux; James M Galloway; Jeffrey A Henderson; William J Howard; Marie Russell; Charlton Wilson; Robert Ratner; John D Sorkin; Jason G Umans; Jerome L Fleg; Mario Stylianou; Elisa Lee; Barbara V Howard
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(10):540-8.
2009: Matthew R Weir; Cheryl A M Anderson
Optimal dietary strategies for reducing incident hypertension.
Hypertension 2009;54(4):698-9.
2009: Fadia T. Shaya; Zhiqiang Lu; Kyongsei Sohn; Matthew R Weir
Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.
P & T : a peer-reviewed journal for formulary management 2009;34(9):490-501.
2009: Wana Manitpisitkul; Erin McCann; Sabrina Lee; Matthew R Weir
Drug interactions in transplant patients: what everyone should know.
Current opinion in nephrology and hypertension 2009;18(5):404-11.
2009: Matthew R Weir; Raymond R Townsend
What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(8):407-10.
2009: Matthew R Weir; Raymond Townsend
Gauging adequacy of cardiovascular disease treatment: importance of estimating glomerular filtration rate and time-varying albuminuria.
Journal of the American Society of Hypertension : JASH 2009;3(4):277-85.
2009: Matthew R Weir; Ravinder K Wali
Optimizing immunosuppression with sirolimus in the first year posttransplantation: experience in the United States.
Transplantation proceedings 2009;41(6 Suppl):S13-7.
2009: Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
The frequency of hyperkalemia and its significance in chronic kidney disease.
Archives of internal medicine 2009;169(12):1156-62.
2009: Henry Krum; Sean P Curtis; Amarjot Kaur; Hongwei Wang; Steven S Smugar; Matthew R Weir; Loren Laine; D Craig Brater; Christopher P Cannon
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
European journal of heart failure 2009;11(6):542-50.
2009: Maha A Mohamed; Matthew R Weir
Renin angiotensin system inhibition in the older person: a review.
Clinics in geriatric medicine 2009;25(2):245-57.
2009: Matthew R Weir
Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
Postgraduate medicine 2009;121(3):90-8.
2009: Matthew R Weir; Ravinder K Wali
Minimizing the risk of chronic allograft nephropathy.
Transplantation 2009;87(8 Suppl):S14-8.
2009: Henry Krum; Gary Swergold; Sean P Curtis; Amarjot Kaur; Hongwei Wang; Steven S Smugar; Matthew R Weir; Loren Laine; D Craig Brater; Christopher P Cannon
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.
Journal of hypertension 2009;27(4):886-93.
2009: Matthew R Weir
Assessing the blood pressure-lowering efficacy of antihypertensive medications: which blood pressures should we use?
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(3):155-8.
2009: Brian D Bradbury; Cathy W Critchlow; Matthew R Weir; Ron Stewart; Mahesh Krishnan; Raymond H Hakim
Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(3):919-25.
2009: Betina T Blak; C. Daniel Mullins; Fadia T. Shaya; Linda Jean Simoni-Wastila; Catherine E Cooke; Matthew R Weir
Prescribing trends and drug budget impact of the ARBs in the UK.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(2):302-8.
2009: Joseph Nogueira; Abdolreza Haririan; Stephen C Jacobs; Matthew R Weir; H A Hurley; Hosam S Al-Qudah; Michael W Phelan; Cinthia Drachenberg; Stephen T Bartlett; Matthew Cooper
The detrimental effect of poor early graft function after laparoscopic live donor nephrectomy on graft outcomes.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(2):337-47.
2009: Eberechukwu Onukwugha; Fadia T. Shaya; Elijah Saunders; Matthew R Weir
Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease.
Ethnicity & disease 2009;19(2):172-8.
2009: Fadia T. Shaya; Dongyi Du; Confidence M Gbarayor; Feride Frech-Tamas; Helen Lau; Matthew R Weir
Predictors of compliance with antihypertensive therapy in a high-risk medicaid population.
Journal of the National Medical Association 2009;101(1):34-9.
2009: Eberechukwu Onukwugha; Matthew R Weir
The dual impact of rehabilitation admission and race/ethnicity on discharges against medical advice.
NeuroRehabilitation 2009;24(1):67-74.
2009: Matthew R Weir
The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Postgraduate medicine 2009;121(1):96-103.
2008: Jerome L Fleg; Mihriye Mete; Barbara V Howard; Jason G Umans; Mary J Roman; Robert E Ratner; Angela Silverman; James M Galloway; Jeffrey A Henderson; Matthew R Weir; Charlton Wilson; Mario Stylianou; Wm James Howard
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
Journal of the American College of Cardiology 2008;52(25):2198-205.
2008: Andrew J Lewin; Matthew R Weir
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
Clinical therapeutics 2008;30(12):2354-65.
2008: Matthew R Weir
Optimizing early de novo immunosuppression with sirolimus.
Transplantation proceedings 2008;40(10 Suppl):S29-31.
2008: Ravinder K Wali; Matthew R Weir
Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Current opinion in organ transplantation 2008;13(6):614-21.
2008: WEN KAO; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berrthier-schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
Nature genetics 2008;40(10):1185-92.
2008: Matthew R Weir
Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?
Current hypertension reports 2008;10(5):385-6.
2008: Ayoola O Akinbamowo; Daniel J Salzberg; Matthew R Weir
Renal consequences of prostaglandin inhibition in heart failure.
Heart failure clinics 2008;4(4):505-10.
2008: Patrick F McArdle; Afshin Parsa; Yen-Pei C Chang; Matthew R Weir; Jeffrey R O'Connell; Braxton D Mitchell; Alan R Shuldiner
Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish.
Arthritis and rheumatism 2008;58(9):2874-81.
2008: Joseph Nogueira; Stephen C Jacobs; Abdolreza Haririan; Michael W Phelan; Matthew R Weir; Stephen L Seliger; Heather A Hurley; Matthew Cooper
A single center comparison of long-term outcomes of renal allografts procured laparoscopically versus historic controls procured by the open approach.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(9):908-14.
2008: Matthew R Weir
Is activated vitamin D supplementation renoprotective?
Hypertension 2008;52(2):211-2.
2008: George L Bakris; Ellen Burgess; Matthew R Weir; Giora Davidai; Stephen Koval
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Kidney international 2008;74(3):364-9.
2008: Bertram L Kasiske; Angelo De Mattos; S M Flechner; L Gallon; H-U Meier-Kriesche; Matthew R Weir; A Wilkinson
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(7):1384-92.
2008: Alan H Gradman; Matthew R Weir; George L Bakris
Newer combination therapies in the management of hypertension: an update.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(5):398-405.
2008: Braxton D Mitchell; Patrick F McArdle; Haiqing Shen; Evadnie Rampersaud; Toni I Pollin; Lawrence F Bielak; Cashell Jaquish; Julie A Douglas; Marie-Hélène Roy-Gagnon; Paul Sack; Rosalie Naglieri; Scott Hines; Richard B Horenstein; Yen-Pei C Chang; Wendy S Post; Kathleen A Ryan; Nga Hong Brereton; Ruth E Pakyz; John D Sorkin; Coleen M Damcott; Jeffrey R O'Connell; Charles Mangano; Mary C Corretti; Robert A Vogel; WILLIAM HERZOG; Matthew R Weir; Patricia A Peyser; Alan R Shuldiner
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study.
American heart journal 2008;155(5):823-8.
2008: Barbara V Howard; Mary J Roman; Richard B Devereux; Jerome L Fleg; James M Galloway; Jeffrey A Henderson; Wm James Howard; Elisa T Lee; Mihriye Mete; Bryce Poolaw; Robert E Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G Umans; Wenyu Wang; Matthew R Weir; Neil J Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
JAMA : the journal of the American Medical Association 2008;299(14):1678-89.
2008: George L Bakris; Matthew R Weir
Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
Postgraduate medicine 2008;120(1):33-42.
2008: Marie-Hélène Roy-Gagnon; Matthew R Weir; John D Sorkin; Kathleen A Ryan; Paul A Sack; Scott Hines; Lawrence F Bielak; Patricia A Peyser; Wendy S Post; Braxton D Mitchell; Alan R Shuldiner; Julie A Douglas
Genetic influences on blood pressure response to the cold pressor test: results from the Heredity and Phenotype Intervention Heart Study.
Journal of hypertension 2008;26(4):729-36.
2008: Matthew R Weir; George L Bakris
Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(2):146-52.
2008: Matthew R Weir
Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuria.
Transactions of the American Clinical and Climatological Association 2008;119():53-61; discussion 61-3.
2008: Matthew R Weir
Risk-based classification of hypertension and the role of combination therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1 Suppl 1):4-12.
2008: Prabhleen Singh; Aihua Deng; Matthew R Weir; Roland C Blantz
The balance of angiotensin II and nitric oxide in kidney diseases.
Current opinion in nephrology and hypertension 2008;17(1):51-6.
2008: Stephen L Seliger; Leslie I Katzel; Jeffrey C Fink; Matthew R Weir; Shari R Waldstein
Renal function and cardiovascular response to mental stress.
American journal of nephrology 2008;28(2):304-10.
2007: Matthew R Weir; Joel M Neutel; Amitabha Bhaumik; Maria Elena De Obaldia; Pablo Lapuerta
The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(12 Suppl 5):23-30.
2007: Matthew R Weir
Direct renin inhibitors: where will they fit in for antihypertensive treatment?
Current hypertension reports 2007;9(5):389-91.
2007: Matthew R Weir
Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
Journal of human hypertension 2007;21(10):770-9.
2007: Martin Thoenes; Peter Bramlage; Bobby V Khan; Bernhard Schieffer; Wilhelm Kirch; Matthew R Weir
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease.
Future cardiology 2007;3(5):519-24.
2007: Matthew R Weir
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Clinical therapeutics 2007;29(9):1803-24.
2007: Matthew R Weir
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Current opinion in nephrology and hypertension 2007;16(5):416-21.
2007: Matthew R Weir; Christopher Bush; David R Anderson; Jack Zhang; Deborah Keefe; Andrew Satlin
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.
Journal of the American Society of Hypertension : JASH 2007;1(4):264-77.
2007: Joseph Nogueira; Matthew R Weir
The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):766-85.
2007: Ghazal Vessal; Anne M Wiland; Benjamin Philosophe; Jeffrey C Fink; Matthew R Weir; David K Klassen
Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
Clinical transplantation 2007;21(4):491-7.
2007: Matthew R Weir; Drew Levy; Nora Crikelair; Ricardo Rocha; Xiangyi Meng; Robert Glazer
Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
American journal of hypertension 2007;20(7):807-15.
2007: Ravinder K Wali; Viresh Mohanlal; Emilio Ramos; Steven Blahut; Cinthia Drachenberg; John C Papadimitriou; Mara Y Dinits-Pensy; Ashish Joshi; Benjamin Philosophe; clarence foster; Charles B Cangro; Joseph Nogueira; Matthew Cooper; Stephen T Bartlett; Matthew R Weir
Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(6):1572-83.
2007: Matthew R Weir
Microalbuminuria and cardiovascular disease.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(3):581-90.
2007: Donna S Hanes; Matthew R Weir
Usefulness of ARBs and ACE inhibitors in the prevention of vascular dementia in the elderly.
The American journal of geriatric cardiology 2007;16(3):175-82.
2007: Matthew R Weir
How big a role should JNC 7 play in the care of hypertensive patients?
The Journal of family practice 2007;56(5):E7-9; author reply E9-10.
2007: Wouter B A Eijkelkamp; Zhongxin Zhang; Giuseppe Remuzzi; Hans-Henrik Parving; Mark E Cooper; William F Keane; Shahnaz Shahinfar; Gilbert W Gleim; Matthew R Weir; Barry M Brenner; Dick De Zeeuw
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Journal of the American Society of Nephrology : JASN 2007;18(5):1540-6.
2007: Matthew R Weir
Is anemia a predictor for mortality and loss of graft function in kidney transplant recipients?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(4):731-2.
2007: Radha Goel; Farhan Majeed; Robert A Vogel; Mary C Corretti; Matthew R Weir; Charles Mangano; Charles S White; Gary D Plotnick; Michael Miller
Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner.
The American journal of cardiology 2007;99(5):743-4.
2007: George L Bakris; Matthew R Weir; Henry R Black
Improving blood pressure control rates: is there more we can do?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):134-42.
2007: Matthew R Weir; Nora Crikelair; Drew Levy; Ricardo Rocha; Venkatram Kuturu; Robert Glazer
Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):103-12.
2007: Matthew R Weir
Is it the low-protein diet or simply the salt restriction?
Kidney international 2007;71(3):188-90.
2007: Matthew R Weir
Calcium channel blockers: their pharmacologic and therapeutic role in hypertension.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7 Suppl 1():5-15.
2007: Daniel J Salzberg; Matthew R Weir
COX-2 inhibitors and cardiovascular risk.
Sub-cellular biochemistry 2007;42():159-74.
2007: Charlotte Jones-Burton; Stephen L Seliger; ROBERTA SCHERER; Shiraz I Mishra; Ghazal Vessal; Jeanine Brown; Matthew R Weir; Jeffrey C Fink
Cigarette smoking and incident chronic kidney disease: a systematic review.
American journal of nephrology 2007;27(4):342-51.
2007: Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Eric Velazquez; Jitendra Gupte; Martin Lefkowitz; Allen Hester; Victor Shi; Matthew R Weir; Sverre E Kjeldsen; Barrie Massie; Shawna Nesbitt; Elizabeth Ofili; Kenneth A Jamerson
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Blood pressure 2007;16(1):13-9.
2007: Matthew R Weir
How do you define "hypertension" in a patient with type 1 diabetes?
Hypertension 2007;49(1):13-4.
2006: Marie Russell; Jerome L Fleg; Wm James Galloway; Jeffrey A Henderson; James Howard; Elisa T Lee; Bryce Poolaw; Robert E Ratner; Mary J Roman; Angela Silverman; Mario Stylianou; Matthew R Weir; Charlton Wilson; Fawn Yeh; Jianhui Zhu; Barbara V Howard
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
American heart journal 2006;152(5):867-75.
2006: Matthew R Weir
Antihypertensive drugs for CVD.
The Journal of family practice 2006;55(10):889-91; author reply 891-2.
2006: Matthew R Weir
Treatment of prehypertension: how soon is soon enough? What therapy should be used?
Current hypertension reports 2006;8(5):393-4.
2006: Fadia T. Shaya; Antoine C El Khoury; C. Daniel Mullins; Dongyi Du; Richard L Skolasky; Hugh Fatodu; Howard Garber; Matthew R Weir
Drug therapy persistence and stroke recurrence.
The American journal of managed care 2006;12(6):313-9.
2006: Matthew R Weir
Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(2):99-105; quiz 106-7.
2006: Antonio M Gotto; George L Blackburn; George E Dailey; Alan J Garber; Scott M Grundy; Burton E Sobel; Matthew R Weir
The metabolic syndrome: a call to action.
Coronary artery disease 2006;17(1):77-80.
2006: Jennifer M Jones; Jung-Jun Park; Jennifer Johnson; Dave Vizcaino; Brian D Hand; Robert E Ferrell; Matthew R Weir; Thomas C. Dowling; Thomas O Obisesan; Michael Brown
Renin-angiotensin system genes and exercise training-induced changes in sodium excretion in African American hypertensives.
Ethnicity & disease 2006;16(3):666-74.
2006: Charlotte Jones-Burton; Shiraz I Mishra; Jeffrey C Fink; Jeanine Brown; Weyinshet Gossa; George L Bakris; Matthew R Weir
An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease.
American journal of nephrology 2006;26(3):268-75.
2005: Shiraz I Mishra; Charlotte Jones-Burton; Jeffrey C Fink; Jeanine Brown; George L Bakris; Matthew R Weir
Does dietary salt increase the risk for progression of kidney disease?
Current hypertension reports 2005;7(5):385-91.
2005: Matthew R Weir
Blood pressure salt sensitivity: a biomeasure of kidney disease susceptibility in diabetics?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2022-4.
2005: Matthew R Weir; Keith C Ferdinand; John M Flack; Kenneth A Jamerson; William Daley; Steven Zelenkofske
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
Hypertension 2005;46(3):508-13.
2005: Ravinder K Wali; Gregory S Wang; Stephen S Gottlieb; Lavanya Bellumkonda; Riple Hansalia; Emilio Ramos; Cinthia Drachenberg; John C Papadimitriou; Meredith A Brisco; Steven Blahut; Jeffrey C Fink; Michael L Fisher; Stephen T Bartlett; Matthew R Weir
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease.
Journal of the American College of Cardiology 2005;45(7):1051-60.
2005: Matthew R Weir
The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
American journal of hypertension 2005;18(4 Pt 2):100S-105S.
2005: Gabriel M Danovitch; David J Cohen; Matthew R Weir; Peter G Stock; William M Bennett; Laura L Christensen; Randall S Sung
Current status of kidney and pancreas transplantation in the United States, 1994-2003.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 2):904-15.
2005: Marvin Moser; Matthew R Weir
Treatment of diabetic hypertensive patients: results of a national survey.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(2):110.
2005: Matthew R Weir
Reduction in microalbuminuria: a biomeasure of therapeutic success?
Hypertension 2005;45(2):181-2.
2005: Fadia T. Shaya; Steven Blume; Christopher M Blanchette; Matthew R Weir; C. Daniel Mullins
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.
Archives of internal medicine 2005;165(2):181-6.
2005: Albert Mimran; Matthew R Weir
Angiotensin-receptor blockers and diuretics--advantages of combination.
Blood pressure 2005;14(1):6-11.
2005: Matthew R Weir; Jeffrey C Fink
Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):176-88.
2005: A Y T Wu; Norella Chiew-Tong Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; Matthew R Weir
An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.
Diabetologia 2005;48(1):17-26.
2005: Matthew R Weir; Roland C Blantz
The clinical utilization of albuminuria as a surrogate measure of cardiovascular disease burden and risk for events: are we there yet?
Current opinion in nephrology and hypertension 2005;14(1):39-41.
2004: Matthew R Weir
Dietary salt, blood pressure, and microalbuminuria.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11 Suppl 3):23-6.
2004: Matthew R Weir
Albuminuria predicting outcome in diabetes: incidence of microalbuminuria in Asia-Pacific Rim.
Kidney international. Supplement 2004;(92):S38-9.
2004: Ravinder K Wali; Cinthia Drachenberg; Hans Hirsch; John C Papadimitriou; Anita Nahar; Viresh Mohanlal; Meredith A Brisco; Stephen T Bartlett; Matthew R Weir; Emilio Ramos
BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression.
Transplantation 2004;78(7):1069-73.
2004: Matthew R Weir
Clinical trials report. Adverse prognostic significance of new diabetes in treated hypertensive subjects.
Current hypertension reports 2004;6(5):365-6.
2004: Matthew R Weir
Healthy diet and blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(7):381-2.
2004: Matthew R Weir; Steven Blahut; Cinthia Drachenburg; Cindi Young; John Papademitriou; David K Klassen; Charles B Cangro; Stephen T Bartlett; Jeffrey C Fink
Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
American journal of nephrology 2004;24(4):379-86.
2004: Matthew R Weir
Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reduction.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(6):315-23; quiz 324-5.
2004: George L Bakris; Matthew R Weir; Michelle Secic; Brett Campbell; Annette Weis-McNulty
Differential effects of calcium antagonist subclasses on markers of nephropathy progression.
Kidney international 2004;65(6):1991-2002.
2004: Matthew R Weir
Blood pressure management in the kidney transplant recipient.
Advances in chronic kidney disease 2004;11(2):172-83.
2004: Cinthia Drachenberg; John C Papadimitriou; Ravinder K Wali; Joseph Nogueira; Susan R Mendley; Hans Hirsch; Charles B Cangro; David K Klassen; Matthew R Weir; Stephen T Bartlett; Emilio Ramos
Improved outcome of polyoma virus allograft nephropathy with early biopsy.
Transplantation proceedings 2004;36(3):758-9.
2004: Donna S Hanes; Anita Nahar; Matthew R Weir
The tissue renin-angiotensin-aldosterone system in diabetes mellitus.
Current hypertension reports 2004;6(2):98-105.
2004: Matthew R Weir
Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(3):134-41; quiz 142-3.
2004: Anne M Wiland; Jeffrey C Fink; Matthew R Weir; Benjamin Philosophe; Steven Blahut; M Ryan Weir; Beth Copenhaver; Stephen T Bartlett
Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial.
Transplantation 2004;77(3):422-5.
2004: Emilio Ramos; Flavio Vincenti; Wei X Lu; Ron Shapiro; Jennifer Trofe; Robert J Stratta; Johann Jonsson; Parmjeet S Randhawa; Cinthia Drachenberg; John C Papadimitriou; Matthew R Weir; Ravinder K Wali
Retransplantation in patients with graft loss caused by polyoma virus nephropathy.
Transplantation 2004;77(1):131-3.
2004: Roland C Blantz; Matthew R Weir
Are the oxygen costs of kidney function highly regulated?
Current opinion in nephrology and hypertension 2004;13(1):67-71.
2004: Jay Lakkis; Matthew R Weir
Pharmacological strategies for kidney function preservation: are there differences by ethnicity?
Advances in renal replacement therapy 2004;11(1):24-40.
2003: Kevin C Mange; Matthew R Weir
Preemptive renal transplantation: why not?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(11):1336-40.
2003: Matthew R Weir; Rhoda S Sperling; Alise S Reicin; Barry J Gertz
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
American heart journal 2003;146(4):591-604.
2003: Jay Lakkis; Wei X Lu; Matthew R Weir
RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease.
Current hypertension reports 2003;5(5):408-17.
2003: Matthew R Weir
Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.
Current hypertension reports 2003;5(5):405-7.
2003: Matthew R Weir
Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(5):330-5.
2003: George L Bakris; Matthew R Weir; Shahnaz Shanifar; Zhongxin Zhang; Janice Douglas; David J van Dijk; Barry M Brenner
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Archives of internal medicine 2003;163(13):1555-65.
2003: Wei X Lu; Jay Lakkis; Matthew R Weir
Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?
Current hypertension reports 2003;5(3):192-8.
2003: George L Bakris; Matthew R Weir
Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(3):202-9.
2003: John C Papadimitriou; Cinthia Drachenberg; David K Klassen; Lillian Gaber; Lorraine C Racusen; Ludek Voska; Charles B Cangro; Emilio Ramos; Ravinder K Wali; Matthew R Weir; Stephen T Bartlett
Histological grading of chronic pancreas allograft rejection/graft sclerosis.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(5):599-605.
2003: Thomas C. Dowling; Andrew E Briglia; Jeffrey C Fink; Donna S Hanes; Paul Light; Lucy Stackiewicz; Chetan S Karyekar; Natalie D. Eddington; Matthew R Weir; William Henrich
Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease.
Clinical pharmacology and therapeutics 2003;73(5):427-34.
2003: Abdolreza Haririan; Omar Hamze; Cinthia Drachenberg; Emilio Ramos; Matthew R Weir; David K Klassen
Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients.
Transplantation 2003;75(8):1186-90.
2003: Anthony N DeMaria; Matthew R Weir
Coxibs--beyond the GI tract: renal and cardiovascular issues.
Journal of pain and symptom management 2003;25(2 Suppl):S41-9.
2003: Macaulay Onuigbo; Matthew R Weir
Evidence-based treatment of hypertension in patients with diabetes mellitus.
Diabetes, obesity & metabolism 2003;5(1):13-26.
2003: Matthew R Weir; Roland C Blantz
Blood pressure and cardiovascular risks: implications of the presence or absence of a nocturnal dip in blood pressure.
Current opinion in nephrology and hypertension 2003;12(1):57-60.
2002: George L Bakris; Matthew R Weir
ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):420-3.
2002: Matthew R Weir
Progressive renal and cardiovascular disease: optimal treatment strategies.
Kidney international 2002;62(4):1482-92.
2002: Matthew R Weir
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers.
Current hypertension reports 2002;4(5):333-5.
2002: Emilio Ramos; Cinthia Drachenberg; John C Papadimitriou; Omar Hamze; Jeffrey C Fink; David K Klassen; Rene C Drachenberg; Anne M Wiland; Ravinder K Wali; Charles B Cangro; Eugene J Schweitzer; Stephen T Bartlett; Matthew R Weir
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
Journal of the American Society of Nephrology : JASN 2002;13(8):2145-51.
2002: Franz H Messerli; Matthew R Weir; Joel M Neutel
Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.
American journal of hypertension 2002;15(6):550-6.
2002: Jeffrey C Fink; Macaulay Onuigbo; Steven Blahut; Robert H Christenson; Dean L Mann; Stephen T Bartlett; Matthew R Weir
Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(5):1096-101.
2002: Abdolreza Haririan; Emilio Ramos; Cinthia Drachenberg; Matthew R Weir; David K Klassen
Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient.
Transplantation 2002;73(8):1350-3.
2002: Jeffrey C Fink; Steven Blahut; Matthew R Weir
Optimal strategies for modeling the reciprocal of creatinine versus time in renal transplant recipients and patients with native chronic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(4):753-61.
2002: David K Klassen; Matthew R Weir; Charles B Cangro; Stephen T Bartlett; John C Papadimitriou; Cinthia Drachenberg
Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience.
Transplantation 2002;73(4):553-5.
2002: Gabriel M Danovitch; Sundaram Hariharan; John D Pirsch; David Rush; David Roth; Emilio Ramos; Randall C Starling; Charles B Cangro; Matthew R Weir
Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation.
Journal of the American Society of Nephrology : JASN 2002;13(2):528-35.
2002: Emilio Ramos; Cinthia Drachenberg; Miguel Portocarrero; Ravinder K Wali; David K Klassen; Jeffrey C Fink; Alan C Farney; Hans Hirsch; John C Papadimitriou; Charles B Cangro; Matthew R Weir; Stephen T Bartlett
BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
Clinical transplants 2002;():143-53.
2002: Matthew R Weir
Renal effects of nonselective NSAIDs and coxibs.
Cleveland Clinic journal of medicine 2002;69 Suppl 1():SI53-8.
2002: Marvin A Konstam; Matthew R Weir
Current perspective on the cardiovascular effects of coxibs.
Cleveland Clinic journal of medicine 2002;69 Suppl 1():SI47-52.
2001: Gregg A Hadley; C Charandee; Matthew R Weir; Donghua Wang; Stephen T Bartlett; Cinthia Drachenberg
CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
Transplantation 2001;72(9):1548-55.
2001: Marvin A Konstam; Matthew R Weir; Alise S Reicin; Deborah Shapiro; Rhoda S Sperling; Eliav Barr; Barry J Gertz
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.
Circulation 2001;104(19):2280-8.
2001: R C Drachenberg; Cinthia Drachenberg; John C Papadimitriou; Emilio Ramos; Jeffrey C Fink; Ravinder K Wali; Matthew R Weir; Charles B Cangro; David K Klassen; A Khaled; Rochelle Cunningham; Stephen T Bartlett
Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1(4):373-81.
2001: Matthew R Weir
Appropriate use of calcium antagonists in hypertension.
Hospital practice (1995) 2001;36(9):47-8, 53-5.
2001: Jeffrey C Fink; Mohammad Salmanullah; Steven Blahut; Matthew R Weir; Robert Sawyer; William Henrich; Michael K Hise
The inevitability of renal function loss in patients with hypercreatinemia.
American journal of nephrology 2001;21(5):386-9.
2001: Matthew R Weir; C Rosenberger; Jeffrey C Fink
Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.
American journal of hypertension 2001;14(9 Pt 1):963-8.
2001: Matthew R Weir
Impact of immunosuppressive regimes on posttransplant diabetes mellitus.
Transplantation proceedings 2001;33(5A Suppl):23S-26S.
2001: Joseph Nogueira; J C Fink And; Matthew R Weir
Recipient outcome after receiving a laparoscopically harvested kidney from a living donor.
Transplantation 2001;72(2):355-6.
2001: Donna S Hanes; Matthew R Weir
The beta blockers: are they as protective in hypertension as in other cardiovascular conditions?
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(4):236-43.
2001: Michael A Weber; Matthew R Weir
Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(4):225-35.
2001: Matthew R Weir; D H Smith; J M Neutel; M P Bedigian
Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake.
American journal of hypertension 2001;14(7 Pt 1):665-71.
2001: Matthew R Weir; Michael A Weber; J M Neutel; J Vendetti; Eric L Michelson; R Y Wang
Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators.
American journal of hypertension 2001;14(6 Pt 1):567-72.
2001: Matthew R Weir
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation.
Transplantation proceedings 2001;33(4 Suppl):19S-28S.
2001: John C Papadimitriou; Cinthia Drachenberg; CO Beskow; Charles B Cangro; Anne M Wiland; David K Klassen; Matthew R Weir; Stephen T Bartlett
Graft-versus-host disease-like features in mycophenolate mofetil-related colitis.
Transplantation proceedings 2001;33(3):2237-8.
2001: Matthew R Weir
Diabetes and hypertension: how low should you go and with which drugs?
American journal of hypertension 2001;14(5 Pt 2):17S-26S.
2001: Matthew R Weir; M T Ward; Steven Blahut; David K Klassen; Charles B Cangro; Stephen T Bartlett; Jeffrey C Fink
Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Kidney international 2001;59(4):1567-73.
2001: Anne M Wiland; Jeffrey C Fink; Benjamin Philosophe; Alan C Farney; Eugene J Schweitzer; John O Colonna; Matthew R Weir; Stephen T Bartlett
Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation.
Transplantation proceedings 2001;33(1-2):1910.
2001: Matthew R Weir
Hypertension in patients with type 2 diabetes.
Hospital practice (1995) 2001;36(1):41-2, 47-8, 51-4; discussion 54.
2001: Bertram L Kasiske; Charles B Cangro; Sundaram Hariharan; Dondald E Hricik; Ronald H Kerman; David Roth; David N Rush; Miguel A Vazquez; Matthew R Weir
The evaluation of renal transplantation candidates: clinical practice guidelines.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1 Suppl 2():3-95.
2001: Matthew R Weir; R C Blantz
Implications from the Heart Outcomes Prevention Evaluation Study.
Current opinion in nephrology and hypertension 2001;10(1):61-3.
2000: Matthew R Weir
Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?
Current hypertension reports 2000;2(6):497-9.
2000: G E Dailey; G H Boden; R H Creech; D G Johnson; Ray E Gleason; F P Kennedy; Larry A Weinrauch; Matthew R Weir; John A D'Elia
Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy.
Metabolism: clinical and experimental 2000;49(11):1491-5.
2000: Steven G Chrysant; Alan B Weder; DA McCarron; M Canossa-Terris; JD Cohen; P A Gunter; Bruce P Hamilton; AJ Lewin; RF Mennella; LW Kirkegaard; Matthew R Weir; MH Weinberger
Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
American journal of hypertension 2000;13(11):1180-8.
2000: George L Bakris; P Whelton; Matthew R Weir; A Mimran; W Keane; E Schiffrin
The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.
Journal of clinical pharmacology 2000;40(8):815-25.
2000: Matthew R Weir; William Henrich
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers.
Current opinion in nephrology and hypertension 2000;9(4):403-11.
2000: Matthew R Weir
When antihypertensive monotherapy fails: fixed-dose combination therapy.
Southern medical journal 2000;93(6):548-56.
2000: David K Klassen; Cinthia Drachenberg; John C Papadimitriou; Charles B Cangro; Jeffrey C Fink; Stephen T Bartlett; Matthew R Weir
CMV allograft pancreatitis: diagnosis, treatment, and histological features.
Transplantation 2000;69(9):1968-71.
2000: George L Bakris; Matthew R Weir
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
Archives of internal medicine 2000;160(5):685-93.
2000: Matthew R Weir; E W Maibach; George L Bakris; H R Black; P Chawla; F H Messerli; J M Neutel; M A Weber
Implications of a health lifestyle and medication analysis for improving hypertension control.
Archives of internal medicine 2000;160(4):481-90.
2000: Matthew R Weir; M Moser
Diuretics and beta-blockers: is there a risk for dyslipidemia?
American heart journal 2000;139(1 Pt 1):174-83.
1999: Ravinder K Wali; Matthew R Weir
Hypertensive cardiovascular disease in African Americans.
Current hypertension reports 1999;1(6):521-8.
1999: Matthew R Weir
Diabetes and hypertension: blood pressure control and consequences.
American journal of hypertension 1999;12(12 Pt 1-2):170S-178S.
1999: Matthew R Weir; V J Dzau
The renin-angiotensin-aldosterone system: a specific target for hypertension management.
American journal of hypertension 1999;12(12 Pt 3):205S-213S.
1999: Matthew R Weir
Are drugs that block the renin-angiotensin system effective and safe in patients with renal insufficiency?
American journal of hypertension 1999;12(12 Pt 3):195S-203S.
1999: Matthew R Weir
Hypertension: goal systolic and diastolic blood pressure.
Current hypertension reports 1999;1(5):411-3.
1999: M Seed; Matthew R Weir
Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. International Quality of Life Multicenter Group.
Clinical therapeutics 1999;21(10):1758-70.
1999: Matthew R Weir
Indicators and treatment of hypertensive heart disease.
Hospital practice (1995) 1999;34(9):93-4, 99-100, 103-4 passim.
1999: Cinthia Drachenberg; David K Klassen; Matthew R Weir; Anne M Wiland; Jeffrey C Fink; Stephen T Bartlett; Charles B Cangro; Steven Blahut; John C Papadimitriou
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
Transplantation 1999;68(3):396-402.
1999: Cinthia Drachenberg; CO Beskow; Charles B Cangro; Patricia Bourquin; Aylin Simsir; Jeffrey C Fink; Matthew R Weir; David K Klassen; Stephen T Bartlett; John C Papadimitriou
Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology.
Human pathology 1999;30(8):970-7.
1999: Matthew R Weir; Jeffrey C Fink
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(1):1-13.
1999: Gregg A Hadley; EA Rostapshova; D M Gomolka; B M Taylor; Stephen T Bartlett; Cinthia Drachenberg; Matthew R Weir
Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
Transplantation 1999;67(11):1418-25.
1999: Joseph Nogueira; Charles B Cangro; Jeffrey C Fink; Eugene J Schweitzer; Anne M Wiland; David K Klassen; J Gardner; John L Flowers; Stephen C Jacobs; Eugene Cho; Benjamin Philosophe; Stephen T Bartlett; Matthew R Weir
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy.
Transplantation 1999;67(5):722-8.
1999: Matthew R Weir; Jeffrey C Fink; Donna S Hanes; J Gardner; David K Klassen; Charles B Cangro; Eugene J Schweitzer; Stephen T Bartlett
Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease.
Transplantation proceedings 1999;31(1-2):1286-7.
1999: Cinthia Drachenberg; John C Papadimitriou; David K Klassen; Matthew R Weir; Charles B Cangro; Jeffrey C Fink; Stephen T Bartlett
Chronic pancreas allograft rejection: morphologic evidence of progression in needle biopsies and proposal of a grading scheme.
Transplantation proceedings 1999;31(1-2):614.
1999: Louis Michael Prisant; J M Neutel; K Ferdinand; V Papademetriou; V DeQuattro; W D Hall; Matthew R Weir
Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.
Journal of the National Medical Association 1999;91(1):40-8.
1998: John C Papadimitriou; Cinthia Drachenberg; Anne M Wiland; David K Klassen; Jeffrey C Fink; Matthew R Weir; Charles B Cangro; Eugene J Schweitzer; Stephen T Bartlett
Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatment.
Transplantation 1998;66(12):1741-5.
1998: Matthew R Weir
The rationale for combination versus single-entity therapy in hypertension.
American journal of hypertension 1998;11(10):163S-169S.
1998: George L Bakris; Matthew R Weir; V DeQuattro; F G McMahon
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Kidney international 1998;54(4):1283-9.
1998: Louis Michael Prisant; J M Neutel; V Papademetriou; V DeQuattro; W D Hall; Matthew R Weir
Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies.
American journal of therapeutics 1998;5(5):313-21.
1998: Matthew R Weir; Efrain Reisin; B Falkner; HG Hutchinson; L Sha; M L Tuck
Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.
American journal of hypertension 1998;11(8 Pt 1):914-20.
1998: Matthew R Weir; L D Dworkin
Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(1):1-22.
1998: John C Papadimitriou; Joseph Nogueira; Jeffrey C Fink; David K Klassen; Stephen T Bartlett; Matthew R Weir; Cinthia Drachenberg
Importance of degree of eosinophilia in inflammatory infiltrates within renal allografts in the response to immunosuppressive treatment.
Transplantation proceedings 1998;30(4):1181.
1998: Vasilios Papademetriou; Louis Michael Prisant; J M Neutel; Matthew R Weir
Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.
The American journal of cardiology 1998;81(11):1363-5.
1998: Matthew R Weir; Steven G Chrysant; DA McCarron; M Canossa-Terris; JD Cohen; P A Gunter; AJ Lewin; RF Mennella; LW Kirkegaard; J H Hamilton; MH Weinberger; Alan B Weder
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
Hypertension 1998;31(5):1088-96.
1998: James L Pool; RM Guthrie; T W Littlejohn; Philip Raskin; A M Shephard; M A Weber; Matthew R Weir; T W Wilson; J Wright; KB Kassler-Taub; R A Reeves
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
American journal of hypertension 1998;11(4 Pt 1):462-70.
1998: Matthew R Weir; Elijah Saunders
Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. Trandolapril Multicenter Study Group.
Journal of human hypertension 1998;12(3):189-94.
1998: Cinthia Drachenberg; John C Papadimitriou; David K Klassen; Matthew R Weir; Stephen T Bartlett
Distribution of alpha and beta cells in pancreas allograft biopsies: correlation with rejection and other pathologic processes.
Transplantation proceedings 1998;30(2):665-6.
1998: John C Papadimitriou; Cinthia Drachenberg; David K Klassen; Matthew R Weir; Stephen T Bartlett
Histologic grading scheme for pancreas allograft rejection: application in the differential diagnosis from other pathologic entities.
Transplantation proceedings 1998;30(2):267.
1998: Eugene J Schweitzer; S Yoon; Jeffrey C Fink; Anne M Wiland; Leslie Anderson; Paul C Kuo; JW Lim; Lynt B Johnson; Alan C Farney; Matthew R Weir; Stephen T Bartlett
Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
Transplantation 1998;65(2):242-8.
1998: Matthew R Weir
Antihypertensive combination therapy.
Drugs of today (Barcelona, Spain : 1998) 1998;34(1):5-9.
1998: Matthew R Weir
Impact of salt intake on blood pressure and proteinuria in diabetes: importance of the renin-angiotensin system.
Mineral and electrolyte metabolism 1998;24(6):438-45.
1997: Matthew R Weir; Leslie Anderson; Jeffrey C Fink; K Gabregiorgish; Eugene J Schweitzer; EW Hoehn-Saric; David K Klassen; Charles B Cangro; Lynt B Johnson; Paul C Kuo; J Y Lim; Stephen T Bartlett
A novel approach to the treatment of chronic allograft nephropathy.
Transplantation 1997;64(12):1706-10.
1997: Steven G Chrysant; Matthew R Weir; Alan B Weder; DA McCarron; M Canossa-Terris; JD Cohen; RF Mennella; LW Kirkegaard; AJ Lewin; MH Weinberger
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients.
Archives of internal medicine 1997;157(21):2489-94.
1997: Franz H Messerli; R E Schmieder; Matthew R Weir
Salt. A perpetrator of hypertensive target organ disease?
Archives of internal medicine 1997;157(21):2449-52.
1997: Donald R Dengel; R S Mayuga; G M Kairis; Andrew P Goldberg; Matthew R Weir
Effect of dietary sodium on insulin sensitivity in older, obese, sedentary hypertensives.
American journal of hypertension 1997;10(9 Pt 1):964-70.
1997: Matthew R Weir; P S Hall; M T Behrens; John M Flack
Salt and blood pressure responses to calcium antagonism in hypertensive patients.
Hypertension 1997;30(3 Pt 1):422-7.
1997: Matthew R Weir
Non-diuretic-based antihypertensive therapy and potassium homeostasis in elderly patients.
Coronary artery disease 1997;8(8-9):499-504.
1997: Efrain Reisin; Matthew R Weir; B Falkner; HG Hutchinson; D A Anzalone; M L Tuck
Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group.
Hypertension 1997;30(1 Pt 1):140-5.
1997: Cinthia Drachenberg; John C Papadimitriou; David K Klassen; Lorraine C Racusen; EW Hoehn-Saric; Matthew R Weir; Paul C Kuo; Eugene J Schweitzer; Lynt B Johnson; Stephen T Bartlett
Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system.
Transplantation 1997;63(11):1579-86.
1997: Barrie Massie; S G Chrysant; A Jain; Matthew R Weir; R Weiss; I Korrin
Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.
Clinical cardiology 1997;20(6):562-8.
1997: Eugene J Schweitzer; Leslie Anderson; Paul C Kuo; Lynt B Johnson; David K Klassen; EW Hoehn-Saric; Matthew R Weir; Stephen T Bartlett
Safe pancreas transplantation in patients with coronary artery disease.
Transplantation 1997;63(9):1294-9.
1997: Matthew R Weir
The influence of dietary salt on the antiproteinuric effect of calcium channel blockers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(5):800-5.
1997: Eugene J Schweitzer; S Yoon; J Hart; Leslie Anderson; R Barnes; D Evans; K Hartman; J Jaekels; Lynt B Johnson; Paul C Kuo; EW Hoehn-Saric; David K Klassen; Matthew R Weir; Stephen T Bartlett
Increased living donor volunteer rates with a formal recipient family education program.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(5):739-45.
1997: Donna S Hanes; P G Nicholson; D D Raval; F L Hooper; M T Behrens; Matthew R Weir
A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
American journal of therapeutics 1997;4(2-3):85-91.
1997: Matthew R Weir
Population characteristics and the modulation of the renin-angiotensin system in the treatment of hypertension.
Journal of human hypertension 1997;11(1):17-21.
1997: Paul C Kuo; Lynt B Johnson; Eugene J Schweitzer; David K Klassen; EW Hoehn-Saric; Matthew R Weir; Cinthia Drachenberg; John C Papadimitriou; Stephen T Bartlett
Solitary pancreas allografts. The role of percutaneous biopsy and standardized histologic grading of rejection.
Archives of surgery (Chicago, Ill. : 1960) 1997;132(1):52-7.
1996: Cinthia Drachenberg; John C Papadimitriou; Matthew R Weir; David K Klassen; EW Hoehn-Saric; Stephen T Bartlett
Histologic findings in islets of whole pancreas allografts: lack of evidence for recurrent cell-mediated diabetes mellitus.
Transplantation 1996;62(12):1770-2.
1996: Lynt B Johnson; Paul C Kuo; Eugene J Schweitzer; L E Ratner; David K Klassen; EW Hoehn-Saric; A dela Torre; Matthew R Weir; J Strange; Stephen T Bartlett
Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization.
Transplantation 1996;62(11):1581-3.
1996: George L Bakris; Matthew R Weir
Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link?
American journal of hypertension 1996;9(12 Pt 2):200S-206S.
1996: Matthew R Weir
Insulin resistance and salt sensitivity. A renal hemodynamic abnormality?
American journal of hypertension 1996;9(12 Pt 2):193S-199S.
1996: Lynt B Johnson; P C Kno; D C Dafoe; Eugene J Schweitzer; E J Alfrey; David K Klassen; EW Hoehn-Saric; Matthew R Weir; Stephen T Bartlett
Double adult renal allografts: a technique for expansion of the cadaveric kidney donor pool.
Surgery 1996;120(4):580-3; discussion 583-4.
1996: Stephen T Bartlett; Eugene J Schweitzer; Lynt B Johnson; Paul C Kuo; John C Papadimitriou; Cinthia Drachenberg; David K Klassen; EW Hoehn-Saric; Matthew R Weir; A L Imbembo
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.
Annals of surgery 1996;224(4):440-9; discussion 449-52.
1996: Eugene J Schweitzer; Cinthia Drachenberg; Leslie Anderson; J C Papadimetriou; Paul C Kuo; Lynt B Johnson; David K Klassen; EW Hoehn-Saric; Matthew R Weir; Stephen T Bartlett
Significance of the Banff borderline biopsy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(4):585-8.
1996: Matthew R Weir; John M Flack; William B Applegate
Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics.
The American journal of medicine 1996;101(3A):83S-92S.
1996: G L Bakris; Matthew R Weir; James R Sowers
Therapeutic challenges in the obese diabetic patient with hypertension.
The American journal of medicine 1996;101(3A):33S-46S.
1996: Donna S Hanes; Matthew R Weir; James R Sowers
Gender considerations in hypertension pathophysiology and treatment.
The American journal of medicine 1996;101(3A):10S-21S.
1996: Matthew R Weir; Louis Michael Prisant; Vasilios Papademetriou; M A Weber; I A Adegbile; D Alemayehu; M P Lefkowitz
Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.
American journal of hypertension 1996;9(9):854-9.
1996: J A Walker; David K Klassen; Frank J Hooper; EW Hoehn-Saric; Eugene J Schweitzer; Lynt B Johnson; Stephen T Bartlett; Matthew R Weir
Late pancreas allograft rejection. Preliminary experience with factors predisposing to rejection.
Transplantation 1996;62(4):539-43.
1996: Donald R Dengel; Andrew P Goldberg; R S Mayuga; G M Kairis; Matthew R Weir
Insulin resistance, elevated glomerular filtration fraction, and renal injury.
Hypertension 1996;28(1):127-32.
1996: L Malinow; J Walker; David K Klassen; David W Oldach; Eugene J Schweitzer; Stephen T Bartlett; Matthew R Weir
Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
Clinical transplantation 1996;10(3):237-42.
1996: Matthew R Weir; M Elkins; C Liss; A J Vrecenak; E Barr; Jonathan Edelman
Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
Clinical therapeutics 1996;18(3):411-28.
1996: David K Klassen; E W Hoen-Saric; Matthew R Weir; John C Papadimitriou; Cinthia Drachenberg; Lynt B Johnson; Eugene J Schweitzer; Stephen T Bartlett
Isolated pancreas rejection in combined kidney pancreas tranplantation.
Transplantation 1996;61(6):974-7.
1996: Matthew R Weir; Donna S Hanes
Hypertension in African Americans: a paradigm of metabolic disarray.
Seminars in nephrology 1996;16(2):102-9.
1996: Matthew R Weir; M L Berger; M L Weeks; C L Liss; N C Santanello
Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group.
The American journal of cardiology 1996;77(7):475-9.
1996: John D Pirsch; C Andrews; D E Hricik; M A Josephson; Alan B Leichtman; C Y Lu; L B Melton; V K Rao; R R Riggio; R J Stratta; Matthew R Weir
Pancreas transplantation for diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;27(3):444-50.
1996: John C Papadimitriou; Cinthia Drachenberg; Leslie Anderson; Stephen T Bartlett; Lynt B Johnson; David K Klassen; EW Hoehn-Saric; Matthew R Weir; Eugene J Schweitzer
Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
Transplantation proceedings 1996;28(1):517-8.
1996: Cinthia Drachenberg; David K Klassen; Stephen T Bartlett; EW Hoehn-Saric; Eugene J Schweitzer; Lynt B Johnson; Matthew R Weir; John C Papadimitriou
Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies.
Transplantation proceedings 1996;28(1):512-3.
1996: Matthew R Weir
Angiotensin-II receptor antagonists: a new class of antihypertensive agents.
American family physician 1996;53(2):589-94.
1996: Matthew R Weir
Can hypertension be prevented? Is salt reduction important in hypertension?
Ethnicity & disease 1996;6(3-4):321-5.
1996: Matthew R Weir
Differing effects of antihypertensive agents on urinary albumin excretion.
American journal of nephrology 1996;16(3):237-45.
1995: Louis Michael Prisant; Matthew R Weir; Vasilios Papademetriou; M A Weber; I A Adegbile; D Alemayehu; M P Lefkowitz; Albert A Carr
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
American heart journal 1995;130(2):359-66.
1995: EM Moy; Barbara Bartman; Matthew R Weir
Access to hypertensive care. Effects of income, insurance, and source of care.
Archives of internal medicine 1995;155(14):1497-502.
1995: Matthew R Weir; J M Gray; R Paster; Elijah Saunders
Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group.
Hypertension 1995;26(1):124-30.
1995: Matthew R Weir; Donald R Dengel; M T Behrens; Andrew P Goldberg
Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.
Hypertension 1995;25(6):1339-44.
1995: Matthew R Weir
Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective.
American journal of hypertension 1995;8(6):635-44.
1995: M C Houston; Matthew R Weir; J Gray; D Ginsberg; C Szeto; P M Kaihlenen; D Sugimoto; M Runde; M Lefkowitz
The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Archives of internal medicine 1995;155(10):1049-54.
1995: Matthew R Weir
Diltiazem: ten years of clinical experience in the treatment of hypertension.
Journal of clinical pharmacology 1995;35(3):220-32.
1995: W H Frishman; J F Burris; W J Mroczek; Matthew R Weir; D Alemayehu; J S Simon; S Y Chen; B S Bryzinski
First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
Journal of clinical pharmacology 1995;35(2):182-8.
1995: David K Klassen; Matthew R Weir; Eugene J Schweitzer; Stephen T Bartlett
Isolated pancreas rejection in combined kidney-pancreas transplantation: results of percutaneous pancreas biopsy.
Transplantation proceedings 1995;27(1):1333-4.
1995: D D Hoelscher; Matthew R Weir; G L Bakris
Hypertension in diabetic patients: an update of interventional studies to preserve renal function.
Journal of clinical pharmacology 1995;35(1):73-80.
1994: Matthew R Weir
Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
Journal of human hypertension 1994;8(9):725-30.
1994: Matthew R Weir; T Fagan; Steven G Chrysant; W Flamenbaum; P M Kaihlanen; M Lueg; D Anzalone
Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
Journal of human hypertension 1994;8(7):531-7.
1994: Daniel Riley; Matthew R Weir; G L Bakris
Renal adaptation to the failing heart. Avoiding a 'therapeutic misadventure'.
Postgraduate medicine 1994;95(8):153-6.
1994: Daniel Riley; Matthew R Weir; G L Bakris
Renal adaptation to the failing heart. Understanding the cascade of responses.
Postgraduate medicine 1994;95(8):141-6, 149-50.
1994: Matthew R Weir; F H Messerli
Optimal titration of ACE inhibitors.
Journal of human hypertension 1994;8(3):153-4.
1994: Richard D Schulick; S C Muluk; Mario Clerici; B L Bermas; Charles S Via; Matthew R Weir; Gene M Shearer
Value of in vitro CD4+ T helper cell function test for predicting long-term loss of human renal allografts.
Transplantation 1994;57(3):480-2.
1993: Richard D Schulick; Matthew R Weir; M W Miller; D J Cohen; B L Bermas; Gene M Shearer
Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs.
Transplantation 1993;56(3):590-6.
1993: Matthew R Weir; P T Lavin; C A Byrnes
Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Clinical therapeutics 1993;15(3):527-38.
1993: Matthew R Weir; J T Wright; K C Ferdinand; C A Cook; D Champion; S Wong; P A Jenkins; B W Kong
Comparison of the efficacy and metabolic effects of nicardipine and hydrochlorothiazide in hypertensive black men and women.
Journal of human hypertension 1993;7(2):141-7.
1993: Matthew R Weir; M L Tuck
Essential hypertension in blacks: is it a metabolic disorder?
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(4 Suppl 1):58-67.
1993: Susan K Keay; M T Behrens; David K Klassen; Matthew R Weir; Eugene J Schweitzer; D Evans; Niel T Constantine; Stephen T Bartlett
Impact asymptomatic HIV-1 infection on renal allograft recipients.
Transplantation proceedings 1993;25(1 Pt 2):1478-80.
1993: Matthew R Weir; D Gomolka; R Peppler; Barry Handwerger
Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium or potassium channels.
Transplantation proceedings 1993;25(1 Pt 1):605-9.
1993: Matthew R Weir; R Peppler; D Gomolka; Barry Handwerger
Calcium channel blockers inhibit cellular uptake of thymidine, uridine and leucine: the incorporation of these molecules into DNA, RNA and protein in the presence of calcium channel blockers is not a valid measure of lymphocyte activation.
Immunopharmacology 1993;25(1):75-82.
1992: Matthew R Weir; R Peppler; D Gomolka; Barry Handwerger
Evidence that the antiproliferative effect of verapamil on afferent and efferent immune responses is independent of calcium channel inhibition.
Transplantation 1992;54(4):681-5.
1992: Matthew R Weir; P T Lavin
Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patients.
Clinical therapeutics 1992;14(5):730-9.
1992: Matthew R Weir
Hypertensive nephropathy: is a more physiologic approach to blood pressure control an important concern for the preservation of renal function?
The American journal of medicine 1992;93(2A):27S-37S.
1992: Stephen S Gottlieb; Shawn Robinson; Matthew R Weir; Michael L Fisher; C M Krichten
Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
American heart journal 1992;124(1):131-6.
1992: David K Klassen; Matthew R Weir; E U Buddemeyer
Simultaneous measurements of glomerular filtration rate by two radioisotopic methods in patients without renal impairment.
Journal of the American Society of Nephrology : JASN 1992;3(1):108-12.
1992: Matthew R Weir; M A Weber; H A Punzi; H M Serfer; S Rosenblatt; W J Cady
A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
Journal of human hypertension 1992;6(2):133-8.
1992: J V Felicetta; H M Serfer; N R Cutler; T J Comstock; G L Huber; Matthew R Weir; K Hafner; G D Park
A dose-response trial of once-daily diltiazem.
American heart journal 1992;123(4 Pt 1):1022-6.
1992: Matthew R Weir; G L Bakris
Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches.
Postgraduate medicine 1992;91(3):87-91, 94-5.
1992: Matthew R Weir; G L Bakris
Risk for renal injury in diabetic hypertensive patients. The physiologic basis for blood pressure control.
Postgraduate medicine 1992;91(3):77-80, 83-4.
1992: Matthew R Weir; David K Klassen; James F Burdick
A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients.
Journal of the American Society of Nephrology : JASN 1992;2(8):1285-90.
1991: Matthew R Weir; X W Li; D Gomolka; R Peppler; C G O'Bryan-Tear; M A Moran
The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662).
Transplantation 1991;52(6):1053-7.
1991: Matthew R Weir; Susan D Wolfsthal
Hypertension and the kidney.
Primary care 1991;18(3):525-44.
1991: Matthew R Weir; David K Klassen; P S Hall; C Schubert; T E Voss; S C Stromatt; J A Brown
Minimization of indomethacin-induced reduction in renal function by misoprostol.
Journal of clinical pharmacology 1991;31(8):729-35.
1991: S C Muluk; Mario Clerici; Charles S Via; Matthew R Weir; P L Kimmel; Gene M Shearer
Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients.
Transplantation 1991;52(2):284-91.
1991: Matthew R Weir; J Josselson; L G Ekelund; M Korc; J L Pool; G H Stein; R A Wolbach; D Champion
Nicardipine as antihypertensive monotherapy: positive effects on quality of life.
Journal of human hypertension 1991;5(3):205-13.
1991: Matthew R Weir
Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
The American journal of medicine 1991;90(5A):32S-36S.
1991: Matthew R Weir
Impact of age, race, and obesity on hypertensive mechanisms and therapy.
The American journal of medicine 1991;90(5A):3S-14S.
1991: Matthew R Weir; B W Kong; P Jenkins; P T Lavin
Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in black patients with hypertension.
Clinical therapeutics 1991;13(3):409-16.
1991: Matthew R Weir; P T Lavin
Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in older patients with hypertension.
Clinical therapeutics 1991;13(3):401-8.
1991: Matthew R Weir; R Peppler; D Gomolka; Barry Handwerger
Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
Transplantation 1991;51(4):851-7.
1991: Matthew R Weir; X W Li; D Gomolka; R Peppler; G O'Bryan-Tear; M Moran
Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC 45662).
Transplantation proceedings 1991;23(1 Pt 2):1074-7.
1991: Matthew R Weir; Michael K Hise
Hypertensive renal damage.
Cardiovascular clinics 1991;21(3):115-32.
1990: Matthew R Weir
Mycobacterium tuberculosis: a disease of growing importance in urban population groups.
New York state journal of medicine 1990;90(12):585-6.
1990: Matthew R Weir; R Haynie; V Vertes; R Pinson; B W Kong; P Jenkins; P T Lavin
A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
Clinical therapeutics 1990;12(6):473-81.
1990: Stephen S Gottlieb; Matthew R Weir
Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure.
The American journal of cardiology 1990;66(11):14D-20D; discussion 20D-21D.
1990: Matthew R Weir
Calcium channel blockers in organ transplantation: important new therapeutic modalities.
Journal of the American Society of Nephrology : JASN 1990;1(3 Suppl 1):S28-38.
1990: S H Croog; B W Kong; S Levine; Matthew R Weir; R M Baume; Elijah Saunders
Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.
Archives of internal medicine 1990;150(8):1733-41.
1990: Elijah Saunders; Matthew R Weir; B W Kong; J Hollifield; J Gray; V Vertes; James R Sowers; Michael B Zemel; C Curry; J Schoenberger
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.
Archives of internal medicine 1990;150(8):1707-13.
1990: X W Li; Matthew R Weir
Radix Tripterygium wilfordii--a Chinese herbal medicine with potent immunosuppressive properties.
Transplantation 1990;50(1):82-6.
1990: K I Plaisance; George L Drusano; A Forrest; Matthew R Weir; HC Standiford
Effect of renal function on the bioavailability of ciprofloxacin.
Antimicrobial agents and chemotherapy 1990;34(6):1031-4.
1990: Matthew R Weir; N D Vlachkis; V DeQuattro; Julie A Douglas; L P Svetkey; S Singh; S C Wiedl; C F Chen; David L Woodward; Elijah Saunders
Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.
Journal of clinical pharmacology 1990;30(5):425-37.
1990: J F Burris; Matthew R Weir; S Oparil; M Weber; W J Cady; W H Stewart
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
JAMA : the journal of the American Medical Association 1990;263(11):1507-12.
1990: Matthew R Weir; C A Cassidy; P S Hall; A Lancaster; C Schubert; A Urick; Elijah Saunders; B W Kong; P Jenkins; P T Lavin
Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
Clinical therapeutics 1990;12(2):139-48.
1990: Matthew R Weir; David K Klassen; S Y Shen; D Sullivan; E U Buddemeyer; Barry Handwerger
Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
Transplantation 1990;49(1):41-7.
1989: Matthew R Weir; David K Klassen; N Hoover; F L Douglas
Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
Journal of clinical pharmacology 1989;29(12):1108-16.
1989: Matthew R Weir
The effects of enalapril on blood pressure, renal hemodynamics, and renal function.
Clinical therapeutics 1989;11(5):685-700.
1989: Matthew R Weir
The enigma of extrapulmonary tuberculosis.
New York state journal of medicine 1989;89(5):251-2.
1989: Matthew R Weir; David K Klassen; S Y Shen; D Sullivan; E U Buddemeyer; Barry Handwerger
Acute effects of intravenous cyclosporine on renal function in healthy humans.
Transplantation proceedings 1989;21(1 Pt 1):915-7.
1989: S Y Shen; C Wood; A N Amin; John C Papadimitriou; Matthew R Weir; T R Coughlin
Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
Transplantation proceedings 1989;21(1 Pt 2):1508-10.
1989: S Y Shen; Matthew R Weir; T R Coughlin
Renal allograft biopsy and conversion of cyclosporine to azathioprine.
Transplantation 1989;47(2):223-9.
1989: Matthew R Weir; R Peppler; D Gomolka; Barry Handwerger
Additive inhibitory effect of cyclosporine and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel.
Transplantation proceedings 1989;21(1 Pt 1):866-70.
1988: Matthew R Weir; D R Salomon; D J Cohen; Charles B Carpenter
Lack of secondary suppressor response in enhanced allografted rats with endogenous suppressor activity in spleen and diminished cytotoxic T cell response.
Transplantation 1988;46(5):731-9.
1988: A Forrest; Matthew R Weir; K I Plaisance; George L Drusano; James L Leslie; HC Standiford
Relationships between renal function and disposition of oral ciprofloxacin.
Antimicrobial agents and chemotherapy 1988;32(10):1537-40.
1988: Matthew R Weir; S Y Shen; F J Dagher; F R Bentley; L J Lesko; John H Sadler
Effects of allostimulation and cyclosporine therapy on cytotoxic antibody production in highly sensitized prospective renal transplant recipients.
Transplantation 1988;46(4):591-4.
1988: Matthew R Weir; James R Sowers
Physiologic and hemodynamic considerations in blood pressure control while maintaining organ perfusion.
The American journal of cardiology 1988;61(16):60H-66H.
1988: Matthew R Weir; Elijah Saunders
Pharmacologic management of systemic hypertension in blacks.
The American journal of cardiology 1988;61(16):46H-52H.
1988: Matthew R Weir; J Josselson
Prevention of end-stage renal disease: a focus of antihypertensive therapy.
Maryland medical journal (Baltimore, Md. : 1985) 1988;37(5):369-72.
1988: Matthew R Weir; R Peppler; D Gomolka; Barry Handwerger
Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
Transplantation proceedings 1988;20(2 Suppl 2):240-4.
1988: Matthew R Weir; C Krichten; A Urick; Elijah Saunders; P T Lavin
Comparison of enalapril and hydrochlorothiazide in mild hypertension and changes in plasma lipid concentrations during therapy.
Clinical therapeutics 1988;10(6):712-24.
1988: Matthew R Weir; M L Henry; M Blackmore; J Smith; M R First; B Irwin; S Shen; G Genemans; J W Alexander; R J Corry
Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
Transplantation 1988;45(1):111-6.
1987: Matthew R Weir; J Josselson; M J Giard; J B Warren; JEFFREY POSNER; Yui-Wing Lam; D E Zaske; Elijah Saunders
Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
The American journal of cardiology 1987;60(17):36I-41I.
1987: George L Drusano; Matthew R Weir; A Forrest; K Plaisance; T Emm; HC Standiford
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Antimicrobial agents and chemotherapy 1987;31(6):860-4.
1987: J Josselson; B A Kyser; Matthew R Weir; John H Sadler
Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1987;9(6):456-61.
1987: S Y Shen; S M Zemel; Matthew R Weir; F J Dagher; F R Bentley
Conversion of cyclosporine to azathioprine in renal transplant patients.
Transplantation proceedings 1987;19(1 Pt 3):2032-6.
1987: Matthew R Weir; S Y Shen; F J Dagher; F R Bentley; L Lesko; John H Sadler
Evaluation of the effects of cyclosporine and HLA-typed source leukocyte transfusions (apheresis by-products) on the immune systems of highly sensitized prospective renal allograft recipients.
Transplantation proceedings 1987;19(1 Pt 1):735-7.
1987: S M Zemel; S Y Shen; Matthew R Weir; F J Dagher; F R Bentley
Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
Transplantation proceedings 1987;19(1 Pt 3):2029-31.
1987: Matthew R Weir; B C Irwin; A W Maters; G Genemans; S Y Shen; PATRICIA CHARACHE; GEORGE WILLIAMS
Morbid outcome of cytomegalovirus-negative transplant recipients receiving cytomegalovirus-positive kidneys.
Transplantation proceedings 1987;19(1 Pt 3):2137-41.
1987: Matthew R Weir; B C Irwin; A W Maters; G Genemans; S Y Shen; PATRICIA CHARACHE; GEORGE WILLIAMS
Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Transplantation 1987;43(2):187-93.
1987: S Y Shen; Matthew R Weir; D R Revie; F J Dagher; F R Bentley; P B Chretien
Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal transplants peripheral T cell subset counts.
Transplantation proceedings 1987;19(1 Pt 2):1776-9.
1986: Matthew R Weir; M Hall-Craggs; S Y Shen; JEFFREY POSNER; S V Alongi; F J Dagher; John H Sadler
The prognostic value of the eosinophil in acute renal allograft rejection.
Transplantation 1986;41(6):709-12.
1986: S Shen; Matthew R Weir; F Dagher; F Bentley; D Revie; J Ordonez; P Chretien
Effect of cyclosporine on total lymphocyte and T-cell counts in renal-transplant recipients.
The New England journal of medicine 1986;314(7):447-8.
1985: S Y Shen; Matthew R Weir; L Litkowski; R Anthony; R Welik; A Kosenko; Paul Light; F J Dagher; John H Sadler
Enzyme-linked immunosorbent assay for serum renal tubular antigen in kidney transplant patients.
Transplantation 1985;40(6):642-7.
1985: S Y Shen; Matthew R Weir; A Kosenko; D R Revie; J V Ordonez; F J Dagher; P Chretien; John H Sadler
Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients.
Transplantation 1985;40(6):620-3.
1985: Matthew R Weir; R L Kirkman; T B Strom; N L Tilney
Liver disease in recipients of long-functioning renal allografts.
Kidney international 1985;28(5):839-44.
1985: Matthew R Weir; G F Thornton
Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature.
The American journal of medicine 1985;79(4):467-78.
1982: R L Kirkman; T B Strom; Matthew R Weir; N L Tilney
Late mortality and morbidity in recipients of long-term renal allografts.
Transplantation 1982;34(6):347-51.